The Efficacy of Human Placenta Mesenchymal Stem Cells Derived Exosomes Injection for Treatment of Complex Anal Fistula in Colorectal Surgery Department of Imam Khomeini Hospital Complex: A Non-randomized Clinical Trial.
Sponsor study identifier
interventional
40
0 countries
N/A
Study Start
September 15, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
November 15, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
February 15, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The goal of this clinical trial is to learn if human placenta mesenchymal stem cells (MSC)-derived exosomes work to treat complex perianal fistula in adults without Crohn's disease. The safety of this treatment will also be learned. The main questions it aims to answer are:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 15, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 22, 2024
Actual (reported)August 23, 2024
Actual (reported)September 15, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
November 15, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
February 15, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The number of fistula openings (orifices) will be assessed before and after our intervention.
clinical improvement
3 months
QoL questionnaire
3 months
human placenta mesenchymal stem cell-derived exosome
routine conventional fistulotomy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
First Submitted
July 22, 2024
First Posted
August 23, 2024
Study Start
September 15, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
November 15, 2024
Estimated (date passed)Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
February 15, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
August 23, 2024
Record last verified: 2024-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: